TOKYO, Aug 25 (Reuters) - Japanese shares rose on Tuesday,
trading close to levels before the COVID-19 crisis hammered
markets early this year, as new developments on the COVID-19
vaccine and treatment fronts lifted sentiment and spurred hopes
of a quicker economic recovery.
The benchmark Nikkei share average .N225 gained 1.71% to
23,378.47 by the midday break, just a hair below 23,386.74, and
a level unseen since Feb. 21. There were 216 advancers on the
index against nine decliners.
The broader Topix .TOPX gained 1.51% to 1,631.33. All but
two of the 33 sector sub-indexes on the Tokyo exchange traded
higher, with airlines .IAIRL.T , textiles .ITXTL.T and
insurance .IINSU.T being the three top performers.
All three major indexes on Wall Street closed higher
overnight as President Donald Trump hailed the U.S. Food and
Drug Administration's authorisation of a COVID-19 treatment that
uses blood plasma from recovered patients. The Trump administration was also considering fast-tracking
an experimental COVID-19 vaccine, the Financial Times reported.
Providing additional support to risk appetite, Japan's
capital Tokyo reported 95 new coronavirus cases on Monday, the
lowest single-day tally since July 8. Separately, worries over U.S.-China relations eased as the
U.S. Trade Representative's Office said top U.S. and Chinese
officials saw progress on resolving issues over the Phase 1
trade deal, and both sides were committed to the success of the
agreement. Among top performing sectors, airlines rose 5.81% after
U.S.-listed peers jumped overnight. ANA Holdings 9202.T
climbed 6.44%, while Japan Airlines 9201.T added 5.07%.
Nintendo 7974.T hit a 12-year high before reversing course
to trade 1.73% lower on profit-taking.
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nikkei nears pre-pandemic levels on COVID-19 treatment hopes
Latest comments
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.